Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. - Wikidata - wikimedia - TriplyDB

Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

http://www.wikidata.org/entity/Q37178718

about

Harnessing the apoptotic programs in cancer stem-like cells Phase I trial of weekly tigatuzumab, an agonistic humanized monoclonal antibody targeting death receptor 5 (DR5)Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.Effect of anti-DR5 and chemotherapy on basal-like breast cancer.hSET1: a novel approach for colon cancer therapy Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy.Effect of niclosamide on basal-like breast cancers.Combined modality therapy with TRAIL or agonistic death receptor antibodies.A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.

P2860

Q26801037-9EC93189-EEAF-4009-88A6-E3B85E7718CF Q33906524-884AE725-9D8C-4126-8130-DA429B3265F1 Q36720866-86D716B2-6676-4E25-BB51-9D54822B49CF Q36731275-790416AD-6495-4BD0-BE7B-EB9A5A6CAB62 Q37215471-542296E3-6380-4E69-9571-CF0075AF89B7 Q37621564-29717BE1-C530-4B53-95FF-816C8ECA5A9A Q37695022-B01CCB7D-1A62-4576-B247-5C0E2ACDE41E Q37832083-ED183FCA-3471-4A2F-946E-1E97EF695DA8 Q38820739-F71BF00B-A6C7-4641-9A78-06CA275928F9 Q39057587-BD2D79AC-F02E-4381-8967-3E1EA681CABD Q39209045-69CB1D73-8231-47BE-9F6B-5613F106F043 Q39983073-7217CA47-46A4-4019-AC8F-6FB1D9F97D29

P2860

Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.

http://www.wikidata.org/entity/Q37178718

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment of human colon cance ...... or in combination with CPT-11.

@en

Treatment of human colon cance ...... or in combination with CPT-11.

@nl

type

label

Treatment of human colon cance ...... or in combination with CPT-11.

@en

Treatment of human colon cance ...... or in combination with CPT-11.

@nl

prefLabel

Treatment of human colon cance ...... or in combination with CPT-11.

@en

Treatment of human colon cance ...... or in combination with CPT-11.

@nl

P1433

Q37178718-8C7BBFAA-C5AB-4C5D-8C50-DD2B8DA5C0DD

P1476

Q37178718-13B69877-6BA0-4C58-8394-AD19C40F0B3C

P2093

Q37178718-42C63F33-5130-4B63-B23B-76155B4F0051

Q37178718-47CBC384-AC90-407E-AE2E-649A2F6C52BA

Q37178718-5F0CFD42-9330-45A3-9FA0-BDE38A2EA5C1

Q37178718-6BFA5A26-D0BB-48D9-9EA8-2B3C99BE4B86

Q37178718-9FFB90F4-3901-49F3-8C32-1F69FE8A2F19

Q37178718-ADA0C328-19F4-467D-8C83-C86329E0CDBD

Q37178718-C12797DA-C838-4A1B-8F5D-67D27E7D9EFB

Q37178718-C2AEECA2-C75E-40DA-9BB8-1FF5EE36EEB5

P2860

Q37178718-091338D0-EB7F-4573-B823-FF760F03B1D0

Q37178718-1AD6A8A7-5832-4749-8A35-1EE72A48907A

Q37178718-3815D3F0-A046-4313-99D5-867D8505C3AE

Q37178718-3B64AC9B-93F8-4868-BC2E-002E3A7130AD

Q37178718-44DF3891-633E-46AF-B010-374D49F0C800

Q37178718-613826B4-2374-46AE-9CC6-4A0845F91767

Q37178718-61C16BE3-F258-416B-95E0-A50E4647825F

Q37178718-6EFBB922-1615-4F14-8100-238AC0A5B33A

Q37178718-A915F5F4-4EF5-42E2-AD76-A8A49AB5275C

Q37178718-AACD955F-C4E0-454F-8ACB-545E1201CBC2

P304

Q37178718-C43CE79F-F11A-4030-9D3C-FF09680E6753

P31

Q37178718-109CF3F9-3012-4E37-918D-E67D11C5BD45

P356

Q37178718-1AFFCE95-1CFE-4388-AC73-BF6AAFD2448E

P407

Q37178718-149768A5-89FF-491C-904B-24F74B751F89

P433

Q37178718-C4045E35-63F4-4BC7-950B-327941E6EFCC

P478

Q37178718-EA040234-DDD6-43D6-976F-626F690E57BC

P577

Q37178718-243FE38C-34A4-4CEB-BB4C-3374C50FB58E

P698

Q37178718-FD3A1E20-C86F-4D35-9DB1-1227B5B078ED

P921

Q37178718-17EB3BEB-9535-4361-A68C-297EE79576DA

Q37178718-3D3BC6B3-9E80-40EC-92F5-75E785604A69

P932

Q37178718-4BF3FD36-D86E-4E5E-81CE-1F50A87C12BA

P356

1078-0432.CCR-07-1392

P1433

Clinical Cancer Research

P1476

Treatment of human colon cance ...... or in combination with CPT-11.

@en

P2093

Albert F LoBuglio

http://www.w3.org/2001/XMLSchema#string

Donald J Buchsbaum

http://www.w3.org/2001/XMLSchema#string

Hyunki Kim

http://www.w3.org/2001/XMLSchema#string

Kurt R Zinn

http://www.w3.org/2001/XMLSchema#string

Li Nan

http://www.w3.org/2001/XMLSchema#string

Patsy G Oliver

http://www.w3.org/2001/XMLSchema#string

Tong Zhou

http://www.w3.org/2001/XMLSchema#string

Wenquan Wang

http://www.w3.org/2001/XMLSchema#string

P2860

HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo

Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications.

Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.

TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.

Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

P304

2180-2189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-1392

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18381960

http://www.w3.org/2001/XMLSchema#string

P921

P932

2676875

http://www.w3.org/2001/XMLSchema#string